Difficulty: Medium
Average Score: 76%
Practice
A 62-year-old woman with mild MS has some mild difficulty with walking. She is interested in becoming more active with walking and is considering walking a 3.1-mile event with her daughter. Which of the following agents may be beneficial in assisting her with improved ambulation?
Correct answer
A
Rationale
The correct answer is A) Dalfampridine. Dalfampridine, also known as 4-aminopyridine, is a potassium channel blocker that can enhance nerve conduction in demyelinated neurons. In multiple sclerosis (MS), demyelination of nerve fibers can lead to impaired nerve signal transmission, affecting ambulation. Dalfampridine has been approved for use in improving walking in patients with MS who experience walking difficulties. By enhancing nerve conduction, it can help improve ambulation and walking speed.
Option B) Fingolimod is a disease-modifying therapy used in MS to reduce relapses, not specifically to improve ambulation.
Option C) Mitoxantrone is a chemotherapeutic agent used in MS but is associated with significant cardiac toxicity and is not indicated for improving ambulation.
Option D) Prednisone is a corticosteroid used in MS exacerbations to reduce inflammation but does not have a direct effect on improving ambulation in chronic MS management.
Educationally, understanding the mechanism of action of drugs used in MS is crucial for healthcare providers to make informed decisions about treatment options for patients with MS. Knowing the specific indications and effects of each drug helps optimize patient care and outcomes. In this case, recognizing the role of Dalfampridine in enhancing ambulation can lead to improved quality of life for the patient with MS who desires to be more active.
Option B) Fingolimod is a disease-modifying therapy used in MS to reduce relapses, not specifically to improve ambulation.
Option C) Mitoxantrone is a chemotherapeutic agent used in MS but is associated with significant cardiac toxicity and is not indicated for improving ambulation.
Option D) Prednisone is a corticosteroid used in MS exacerbations to reduce inflammation but does not have a direct effect on improving ambulation in chronic MS management.
Educationally, understanding the mechanism of action of drugs used in MS is crucial for healthcare providers to make informed decisions about treatment options for patients with MS. Knowing the specific indications and effects of each drug helps optimize patient care and outcomes. In this case, recognizing the role of Dalfampridine in enhancing ambulation can lead to improved quality of life for the patient with MS who desires to be more active.